Clinical trials: Subcutaneous Injection
Anemia
A Study of Subcutaneous Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia
This single arm study assessed the efficacy and safety of subcutaneous methoxy polyethylene glycol-epoetin beta (Mircera), a continuous erythropoietin receptor activator (C.E.R.A.), for correction and/or maintenance of hemoglobin…
- Trial name
- NCT00642668
- Testing
- methoxy polyethylene glycol-epoetin beta
- Where
- 32 sites in Belgium
- Volunteers
- 35 people
- Sponsor
- Hoffmann-La Roche